Obesity Clinical Trial
Official title:
Effect of Pasta as Part of Low Glycemic Index Diets on Body Weight and Markers of Adiposity in Humans: A Series of Systematic Reviews and Meta-analyses to Provide Evidence-based Guidance for Nutrition Guidelines Development
Pasta is an important example of a food which can lower the glycemic index (GI) of the diet, a property that has been exploited extensively in studies of low GI dietary patterns. Although low-GI dietary patterns have been shown to improve body weight, glycemic control and blood lipids, it is unclear whether pasta as part of low-GI dietary patterns will improve measures of global adiposity including body weight. The lack of high quality knowledge syntheses to support evidence-based dietary guidance of the cardiometabolic benefits of pasta represents an urgent call for stronger evidence. To improve evidence-based guidance for pasta recommendations, the investigators propose to conduct a systematic review and meta-analysis of controlled studies in humans to assess the effect of eating pasta as part of a low GI diet compared to other diets on measures of adiposity (body fatness) in humans. The systematic review process allows the combining of the results from many studies in order to arrive at a pooled estimate, similar to a weighted average, of the true effect. The investigators will be able to explore whether eating pasta as part of a low GI diet has different effects between men and women, in different age groups and in people with high or normal sugar. The findings of this proposed knowledge synthesis will help improve the health of Canadians through informing recommendations for the general public, as well as those at risk of heart disease and diabetes.
Background: Overweight and obesity is a key modifiable risk factor for the prevention and
management of type 2 diabetes, dyslipidemia, hypertension, CVD and certain cancers. Low-GI
dietary patterns have been shown to improve body weight, among other risk factors including
glycemic control and blood lipids, and have been associated with risk reduction of type 2
diabetes and CVD. Current clinical practice guidelines suggest the replacement of high GI
foods with low GI foods for improvement of glycemic control and cardiovascular risk factors.
Pasta is an important example of a food which can lower the GI of the diet, a property that
has been exploited extensively in studies of low GI dietary patterns. However, it is unclear
whether pasta as part of low-GI dietary patterns will improve measures of global adiposity,
including body weight in addition to other markers of adiposity.
Need for a review: The lack of high quality knowledge syntheses to support evidence-based
dietary guidance on pasta represents an urgent call for stronger evidence. A systematic
review and meta-analysis of randomized controlled trials remains the "Gold Standard" of
evidence to support clinical practice guidelines and public health policy. By pooling the
totality of the available evidence, a systematic reviews and meta-analyses of randomized
controlled trials would provide the best estimate of the effect of pasta on measures of
global adiposity relevant to the prevention and management of overweight and obesity.
Objectives: To provide evidence-based guidance for public health policy, health claims, and
nutrition guidelines relating to pasta as part of low GI dietary pattern, the investigators
will conduct a systematic review and meta-analysis of randomized controlled trials to assess
the effect of past as part of a low GI diet on markers of global adiposity, including body
weight in addition to others as well as regional markers of adiposity which have
demonstrated clinical relevance.
Design: The planning and conduct of the proposed meta-analyses will follow the Cochrane
handbook for systematic reviews of interventions. The reporting will follow the Preferred
Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines.
Data sources: MEDLINE, EMBASE and The Cochrane Central Register of Controlled Trials will be
searched using appropriate search terms.
Study selection: Randomized controlled trials that investigate the effect of pasta as part
of a low GI dietary pattern on body weight and other markers of adiposity in humans will be
included. Trials that are less than 3 weeks diet duration, do not have a control group,
include pregnant women, breast feeding women or children, or do not report data on markers
of body weight will be excluded.
Data extraction: Two independent investigators will extract information about study design,
sample size, subject characteristics, GI/GL diet, follow-up, and the composition of the
background diets. Mean ± SEM values will be extracted for all outcomes. Standard
computations and imputations will be used to derive missing data. Risk of bias will be
assessed using the Cochrane Collaboration risk of bias tool.
Outcome: The primary outcome will be mean differences in body weight as a global marker of
adiposity which has demonstrated clinical relevance. Secondary outcomes will be mean
differences in other markers of global adiposity with clinical relevance including BMI and
percentage body fat, as well as regional markers of adiposity with clinical relevance
including waist circumference, waist-to-hip ratio, sagittal abdominal diameter, and visceral
adipose tissue [VAT] by imaging modalities.
Data synthesis: Pooled analysis will be conducted using the Generic Inverse Variance method.
Separate analyses will be conducted for children and adults. Analyses will be further
stratified by metabolic phenotype (normal weight, overweight/obese, metabolic syndrome
criteria, diabetes, etc.). Random-effects models will be used even in the absence of
statistically significant between-study heterogeneity, as they yield more conservative
summary effect estimates in the presence of residual heterogeneity. Fixed-effects models
will only be used where there is <5 included studies. Paired analyses will be applied to all
crossover trials. Heterogeneity will be tested by the Cochran Q statistic and quantified by
the I2 statistic. Sources of heterogeneity will be explored by sensitivity and subgroup
analyses. If there are ≥ 10 trial comparisons, then a priori subgroup analyses will also be
conducted by dose (<100g/day, ≥100g/day), comparator, follow-up (<6-months, ≥6-months),
baseline body weight (BMI ≤25 >25kg/m2), design (parallel, crossover), energy balance
(negative, neutral, positive), GI (absolute level [≤55, >55], within-treatment change,
between-treatment change), fat intake (absolute level [<30%, ≥30% energy], within-treatment
change, between-treatment change), carbohydrate intake (absolute level [<50%, ≥50% energy],
within-treatment change, between-treatment change), protein intake (absolute level [<20%,
≥20% energy], within-treatment change, between-treatment change), dietary fibre intake
(absolute level [<25g/day, ≥25g/day], within-treatment change, between-treatment change),
and risk of bias. Meta-regression will assess the significance of categorical and continuous
subgroup analyses. Non-linear relationships will be assessed by spline curve modeling (the
MKSPLINE procedure) to assess whether there is a threshold for benefit. If there are ≥10
trial comparisons, then publication bias will be assessed by inspection of funnel plots and
the Egger and Begg tests. In the presence of significant publication bias, an adjustment for
funnel plot asymmetry will be attempted by using the Duval and Tweedie trim-and-fill method.
Evidence Assessment: The strength of the evidence for each outcome will be assessed using
the Grading of Recommendations Assessment, Development and Evaluation (GRADE).
Knowledge translation plan: Results will be disseminated through traditional means such as
interactive presentations at local, national, and international scientific meetings and
publication in high impact factor journals. Innovative means such as webcasts with e-mail
feedback mechanisms will also be used. Knowledge Users will act as knowledge brokers
networking among opinion leaders and different adopter groups to increase awareness at each
stage. Four Knowledge Users will also participate directly as members of nutrition
guidelines committees. Target adopters will include the clinical practice, public health,
industry, research communities, and patient groups. Feedback will be incorporated and used
to guide analyses and improve key messages at each stage.
Significance: The proposed project will aid in knowledge translation related to the role of
pasta as part of a healthy low-GI-dietary pattern on health outcomes strengthening the
evidence-base for guidelines and improving health outcomes, by educating healthcare
providers and patients, stimulating industry innovation, and guiding future research design.
;
Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |